Reginald Love insider trades: Strata Critical Medical (SRTA) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Reginald reports to the SEC
Open-market buys and sales
7 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 10, 2026 | SRTA | ↓ Sell | 5,091 | $5.75 | $29K | Direct | Aug 13, 2026 (3d) |
| Nov 20, 2025 | SRTA | ↓ Sell | 11,000 | $4.37 | $48K | Direct | Nov 24, 2025 (4d) |
| Nov 19, 2025 | SRTA | ↓ Sell | 11,000 | $4.31 | $47K | Direct | Nov 20, 2025 (1d) |
| Dec 13, 2024 | BLDE | ↓ Sell | 5,091 | $4.05 | $21K | Direct | Dec 17, 2024 (4d) |
| Jun 10, 2024 | BLDE | ↑ Buy | 5,091 | $2.98 | $15K | Direct | Jun 12, 2024 (2d) |
| Nov 24, 2023 | BLDE | ↓ Sell | 20,000 | $3.21 | $64K | Direct | Nov 27, 2023 (3d) |
| Jun 21, 2019 | BSIG | ↓ Sell | 364 | $11.01 | $4K | Direct | Jun 24, 2019 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other SRTA insiders
Open-market trades in the last 12 months
About Reginald Love's insider trades
Reginald Love is a director at Strata Critical Medical (SRTA). Since Jun 21, 2019, Reginald has reported 1 open-market purchase worth $15K and 6 sales worth $214K on SEC Form 4. In the last 12 months: 3 sales ($125K).
Their filings also include grants and awards (8 filings), option exercises (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SRTA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.